(L-R) Samta Kundu (COO), Jake Becraft (CEO), Tasuku Kitada (head of R&D) [Strand Therapeutics]
A pair of former MIT researchers think they've unlocked the next generation of mRNA using synbio 'logic circuits'
The time of mRNA is in full swing as Moderna and Pfizer/BioNTech have blown the doors off the field. But in drug developers’ eyes, current …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
